Insmed (INSM) Cash from Investing Activities Growth (5y) (2015 - 2026)
Insmed (INSM) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Insmed | 22.60 Bn | 21.38 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195.90% |
| Dec 31, 2025 | 203.86% |
| Sep 30, 2025 | -299.72% |
| Jun 30, 2025 | 161.86% |
| Mar 31, 2025 | 100.02% |
| Dec 31, 2024 | 64.66% |
| Sep 30, 2024 | -133.07% |
| Jun 30, 2024 | 8.56% |
| Mar 31, 2024 | 137.34% |
| Dec 31, 2023 | 18.93% |
| Sep 30, 2023 | 42.43% |
| Jun 30, 2023 | -149.30% |
| Mar 31, 2023 | 57.70% |
| Dec 31, 2022 | 69.39% |
| Sep 30, 2022 | 157.20% |
| Jun 30, 2022 | -46.05% |
| Mar 31, 2022 | -200.04% |
| Dec 31, 2021 | -131.40% |
| Sep 30, 2021 | -45.24% |
| Jun 30, 2021 | -17.74% |